Organometallics
Article
boxamide (1.50 g, 4.57 mmol, 1.00 equiv) in CH2Cl2 (15 mL) at 0 °C
were added successively tosyl chloride (1.13 g, 5.94 mmol, 1.30 equiv)
and triethylamine (1.39 mL, 1.01 g, 10.0 mmol, 2.20 equiv). The
cooling bath was removed, and the reaction mixture was stirred for 20
h at room temperature. After addition of saturated aqueous NH4Cl
solution (15 mL), the phases were separated, and the aqueous phase
was extracted with CH2Cl2 (3 × 20 mL). The combined organic
phases were washed with saturated aqueous NaCl solution (50 mL),
dried over Na2SO4, and concentrated under reduced pressure. The
residue was purified by flash column chromatography on silica gel
using cyclohexane/ethyl acetate (10/1) as eluent, affording ferrocenyl
oxazoline 8 (1.04 g, 3.34 mmol, 73%) as a brown solid. Mp: 138.7 °C
(benzene). Rf = 0.06 (cyclohexane/ethyl acetate 10/1). GLC (HP-5):
1,2-Cl2C6D4): δ 0.61 (s, 3H), 0.77 (s, 9H), 0.81 (s, 9H), 4.08 (dd, J =
10.1, 7.8 Hz, 1H), 4.86 (dd, J = 10.0, 8.0 Hz, 1H), 5.00 (dd, J = 10.2,
10.4 Hz, 1H), 7.36−7.42 (m, 1H), 7.42−7.57 (m, 2H), 7.62−7.66 (m,
1H). 13C NMR (126 MHz, 1,2-Cl2C6D4): δ −5.1, 18.7, 25.28, 25.32,
33.9, 71.1, 79.1, 124.6 (br m), 126.4, 132.4, 133.5, 134.2, 136.8 (d, J =
238.1 Hz), 137.2, 138.7 (d, J = 241.8 Hz), 140.9, 148.8 (d, J = 241.8
Hz), 181.8. 1H,15N HMQC NMR (700/71 MHz, 1,2-Cl2C6D4): δ
151.2. 1H,29Si HMQC NMR (500/99 MHz, 1,2-Cl2C6D4): δ 24.7.
1
NMR spectroscopic data for (SiR,S)-1 are as follows. H NMR (500
MHz, 1,2-Cl2C6D4): δ 0.51 (s, 3H), 0.85 (s, 9H), 0.89 (s, 9H), 4.04
(dd, J = 12.6, 9.6 Hz, 1H), 4.64 (dd, J = 12.7, 9.6 Hz, 1H), 4.92 (dd, J
= 9.6, 9.6 Hz, 1H), 7.36−7.42 (m, 1H), 7.42−7.57 (m, 2H), 7.57−7.61
(m, 1H). 13C NMR (126 MHz, 1,2-Cl2C6D4): δ −8.6, 20.2, 25.97,
25.99, 32.0, 73.0, 77.7, 124.6 (br m), 125.8, 127.7, 133.5, 134.2, 136.8
(d, J = 238.1 Hz), 137.3, 138.7 (d, J = 241.8 Hz), 142.3, 148.8 (d, J =
241.8 Hz), 182.9. 1H,15N HMQC NMR (700/71 MHz, 1,2-Cl2C6D4):
̃
tR = 19.4 min. IR (ATR): ν 3092 (w), 2954 (s), 1658 (s), 1473 (m),
1356 (m), 1307 (m), 1265 (m), 1195 (m), 1103 (s), 1017 (s), 967 (s),
811 (s) cm−1. HRMS (ESI): calculated for C17H22FeNO [M + H]+,
1
δ 151.3. H,29Si HMQC NMR (500/99 MHz, 1,2-Cl2C6D4): δ 24.2.
1
312.1045; found, 312.1053. H NMR (500 MHz, C6D6): δ 0.91 (s,
11B NMR (160 MHz, 1,2-Cl2C6D4): −16.2. 19F NMR (471 MHz, 1,2-
9H), 3.78 (dd, J = 10.2, 8.2 Hz, 1H), 3.85−3.93 (m, 2H), 4.02 (mc,
2H), 4.09 (s, 5H), 4.90 (mc, 1H), 4.94 (mc, 1H). 13C NMR (126 MHz,
C6D6): δ 26.2, 33.6, 68.2, 69.6, 69.8, 70.28, 70.35, 72.0, 76.8, 165.2.
Cl2C6D4): −166.1, −162.3, −131.7.
(SiS*,S,Sp)-tert-Butyl(2-(4-tert-butyloxazolin-2-yl)ferrocenyl)-
methylsilylium Tetrakis(pentafluorophenyl)borate (2). This was
prepared from (SiS*,S,Sp)-tert-butyl(2-(4-tert-butyloxazolin-2-yl)-
ferrocenyl)methylsilane (6; 20.6 mg, 50.1 μmol, 1.00 equiv) and
[Ph3C]+[B(C6F5)4]− (50.7 mg, 55.0 mmol, 1.10 equiv) according to
GP3. The silicon cation 2 was obtained along with small amounts of
unreacted silane 6. NMR spectroscopic data for (SiS,S,Sp)-2 are as
20
Specific rotation [α]D = −183.8 (c = 0.86, CHCl3). The analytical
and spectroscopic data are in accordance with those reported.24
(SiS*,S,Sp)-tert-Butyl(2-(4-tert-butyloxazolin-2-yl)ferrocenyl)-
methylsilane (6). To a solution of ferrocenyl oxazoline 8 (141 mg,
0.452 mmol, 1.00 equiv) and TMEDA (0.89 mL, 68 mg, 0.59 mmol,
1.3 equiv) in n-hexane (10 mL) cooled to −78 °C was added nBuLi
(1.4 M in hexane fractions, 0.43 mL, 0.59 mmol, 1.3 equiv) dropwise,
and the resulting mixture was stirred for 2 h at −78 °C and warmed to
0 °C over a period of 1 h. tert-Butylchloro(methyl)silane (86.5 mg,
0.633 mmol, 1.40 equiv) was added dropwise, and the reaction mixture
was warmed to room temperature over a period of 20 h. After dilution
with tert-butyl methyl ether (15 mL) and addition of saturated
aqueous sodium bicarbonate solution (20 mL), the phases were
separated, and the aqueous phase was extracted with tert-butyl methyl
ether (3 × 10 mL). The combined organic phases were washed with
saturated aqueous NaCl solution (15 mL), dried over Na2SO4, and
concentrated under reduced pressure. The residue was purified by
flash column chromatography on silica gel using cyclohexane/ethyl
acetate (20/1) as eluent, affording silane 6 (171 mg, 0.416 mmol, 92%,
dr = 61:39) as a brown oil. For the generation of the corresponding
silicon cation, the silane was azeotropically dried by addition and
subsequent evaporation of dry benzene under vacuum (3×). Rf = 0.17
(cyclohexane/ethyl acetate 20/1). GLC (HP-5): tR = 22.2 min (major
1
follows. H NMR (500 MHz, 1,2-Cl2C6D4): δ 0.71 (s, 9H), 0.79 (s,
3H), 0.81 (s, 9H), 3.79 (dd, J = 9.8, 8.1 Hz, 1H), 4.17 (s, 5H), 4.58−
4.64 (m, 1H), 4.71−4.80 (m, 2H), 4.82−4.88 (m, 2H). 13C NMR
(126 MHz, 1,2-Cl2C6D4): δ −2.8, 18.9, 25.0, 25.5, 33.3, 66.9, 69.5,
71.8, 72.3, 74.4, 77.9, 78.8, 80.6, 124.7 (br m), 136.8 (d, 241.8 Hz),
138.7 (d, J = 239.2 Hz), 148.8 (d, J = 244.5 Hz), 188.1. 1H,15N
HMQC NMR (700/71 MHz, 1,2-Cl2C6D4): δ 147.7. 29Si DEPT NMR
(99 MHz, 1,2-Cl2C6D4): δ 26.4. NMR spectroscopic data for
(SiR,S,Sp)-2 are as follows. 1H NMR (500 MHz, 1,2-Cl2C6D4): δ
0.22 (s, 3H), 0.82 (s, 9H), 1.17 (s, 9H), 3.62−3.68 (m, 1H), 4.19 (s,
5H), 4.65−4.70 (m, 1H), 4.72−4.76 (m, 1H), 4.76 (m, 1H), 4.82−
4.88 (m, 2H). 13C NMR (126 MHz, 1,2-Cl2C6D4): δ −4.5, 18.9, 21.0,
24.9, 26.8, 66.5, 69.5, 72.2, 72.3, 75.7, 78.2, 79.4, 80.7, 124.7 (br m),
136.8 (d, 241.8 Hz), 138.7 (d, J = 239.2 Hz), 148.8 (d, J = 244.5 Hz),
1
188.6. H,15N HMQC NMR (700/71 MHz, 1,2-Cl2C6D4): δ 152.5.
29Si DEPT NMR (99 MHz, 1,2-Cl2C6D4): δ 25.4. 11B NMR (160
MHz, 1,2-Cl2C6D4): −16.0. 19F NMR (471 MHz, 1,2-Cl2C6D4):
−165.7, −161.9, −131.4.
̃
diastereomer), tR = 22.1 min (minor diastereomer). IR (ATR): ν 3096
(w), 2951 (m), 2852 (m), 2139 (w), 1637 (m), 1547 (w), 1462 (m),
1360 (m), 1248 (m), 1139 (m), 1056 (w), 996 (m), 870 (m), 813 (s),
719 (m) cm−1. HRMS (ESI): calculated for C22H34FeNOSi [M + H]+:
412.1754; found, 412.1738. Specific rotation [α]D20 = 160.0 (c = 0.58,
CHCl3). NMR spectroscopic data for the major diastereomer are as
follows. 1H NMR (500 MHz, C6D6): δ 0.38 (d, J = 3.8 Hz, 3H), 0.92
(s, 9H), 1.13 (s, 9H), 3.71 (dd, J = 10.2, 8.2 Hz, 1H). 3.81−3.89 (m,
2H), 4.05 (mc, 1H), 4.10 (s, 5H), 4.19−4.22 (m, 1H), 4.94 (q, J = 3.8
Hz, 1H), 5.05 (mc, 1H). 13C NMR (126 MHz, C6D6): δ −6.5, 18.0,
26.2, 28.1, 33.5, 68.0, 68.3,† 70.3, 72.8, 73.7, 76.9, 77.4, 79.7, 165.2 [†
2-(2-Bromophenyl)-1,3-dithiolane (11a). According to GP1,
ethane-1,2-dithiol (0.91 mL, 1.0 g, 11 mmol, 2.0 equiv) and iodine
(0.14 g, 0.54 mmol, 0.10 equiv) were added to a solution of 2-
bromobenzaldehyde (0.63 mL, 1.0 g, 5.4 mmol, 1.0 equiv) in CHCl3
(23 mL), and the resulting mixture was stirred at room temperature
for 15 h. After addition of aqueous NaOH solution (2 N, 20 mL), the
phases were separated, and the aqueous phase was extracted with tert-
butyl methyl ether (3 × 10 mL). The combined organic phases were
washed with saturated aqueous NaCl solution (10 mL), dried over
Na2SO4, and concentrated under reduced pressure. The residue was
purified by flash column chromatography on silica gel using
cyclohexane as eluent, affording dithiolane 11a (1.14 g, 4.36 mmol,
81%) as a colorless oil. Rf = 0.47 (cyclohexane/ethyl acetate 30/1).
1
from the HMBC experiment]. H,15N HMQC NMR (700/71 MHz,
C6D6): δ 226.4. 29Si DEPT NMR (99 MHz, C6D6): δ −6.1. NMR
spectroscopic data for the minor diastereomer are as follows. 1H NMR
(500 MHz, C6D6): δ 0.78 (d, J = 3.7 Hz, 3H), 0.90 (s, 9H), 1.15 (s,
9H), 3.68 (dd, J = 9.7, 8.5 Hz, 1H), 3.75−3.83 (m, 2H), 4.14 (s, 5H),
4.19−4.22 (m, 1H), 4.31 (mc, 1H), 4.47 (q, J = 3.6 Hz, 1H), 5.05 (mc,
1H). 13C NMR (126 MHz, C6D6): δ −5.0, 18.0, 26.2, 28.2, 33.6, 68.0,
̃
GLC (HP-5): tR = 17.7 min. IR (ATR): ν 3053 (w), 2918 (w), 2826
(w), 1458 (m), 1435 (m), 1273 (m), 1239 (w), 1158 (w), 1111 (w),
1018 (s), 843 (m), 729 (s), 683 (m) cm−1. HRMS (ESI): calculated
1
for C9H9BrS2 [M]+, 261.9309; found, 261.9264. H NMR (500 MHz,
1
68.3, 70.2, 72.5, 74.1, 77.0, 77.2, 79.7, 165.2. H,15N HMQC NMR
C6D6): δ 2.64−2.71 (m, 2H), 2.74−2.81 (m, 2H), 6.15 (s, 1H), 6.60
(mc, 1H), 6.93 (mc, 1H), 7.26 (mc, 1H), 7.85 (mc, 1H). 13C NMR (126
MHz, C6D6): δ 39.6, 55.6, 124.5, 127.7, 129.2, 129.8, 133.0, 141.0.
2-(2-Bromophenyl)-2-methyl-1,3-dithiolane (11b). According
to GP1, ethane-1,2-dithiol (0.17 mL, 0.19 g, 2.0 mmol, 2.0 equiv) and
iodine (25.6 mg, 0.101 mmol, 0.101 equiv) were added to a solution of
2′-bromoacetophenone (0.14 mL, 0.20 g, 1.0 mmol, 1.0 equiv) in
CHCl3 (4.3 mL), and the resulting mixture was stirred at room
temperature for 5 h. After addition of aqueous NaOH solution (2 N,
(700/71 MHz, C6D6): δ 224.3. 29Si DEPT NMR (99 MHz, C6D6): δ
0.8.
(SiS*,S)-tert-Butyl(2-(4-tert-butyloxazolin-2-yl)phenyl)-
methylsilylium Tetrakis(pentafluorophenyl)borate (1). This was
prepared from (SiS*,S)-tert-butyl(2-(4-tert-butyloxazolin-2-yl)phenyl)-
methylsilane (5; 23.9 mg, 78.7 μmol, 1.00 equiv) and [Ph3C]+[B-
(C6F5)4]− (77.0 mg, 83.5 μmol, 1.06 equiv) according to GP3. NMR
1
spectroscopic data for (SiS,S)-1 are as follows. H NMR (500 MHz,
3624
dx.doi.org/10.1021/om500570d | Organometallics 2014, 33, 3618−3628